Longitudinal Changes in Individual BrainAGE in Healthy Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
Abstract
We recently proposed a novel method that aggregates the multidimensional aging pattern across the brain to a single value. This method proved to provide stable and reliable estimates of brain aging – even across different scanners. While investigating longitudinal changes in BrainAGE in about 400 elderly subjects, we discovered that patients with Alzheimer’s disease and subjects who had converted to AD within 3 years showed accelerated brain atrophy by +6 years at baseline. An additional increase in BrainAGE accumulated to a score of about +9 years during follow-up. Accelerated brain aging was related to prospective cognitive decline and disease severity. In conclusion, the BrainAGE framework indicates discrepancies in brain aging and could thus serve as an indicator for cognitive functioning in the future.
References
2012). Gray matter atrophy rate as a marker of disease progression in AD. Neurobiology of Aging, 33, 1194–1202.
(2003). Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurology, 2(2), 79–88.
(2005). Unified segmentation. Neuroimage, 26, 839–851.
(2006). Pattern recognition and machine learning. New York, NY: Springer.
(2010). Age-correlated gene expression in normal and neurodegenerative human brain tissues. PLoS One, 5(9), e13098.
(2009). Risk factors for dementia. Journal of the Formosan Medical Association, 108, 754–764.
(2005). Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. Neuroimage, 27, 934–946.
(2006). Vitamin B12, folic acid, and the prevention of dementia. New England Journal of Medicine, 354, 2817–2819.
(1988). Mini-Mental State Examination (MMSE). Psychopharmacology Bulletin, 24, 689–692.
(2005). Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Transactions on Medical Imaging, 24, 1548–1565.
(2010). Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care, 33, 1309–1314.
(2008). MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology, 71, 819–825.
(2009). Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology, 72, 1906–1913.
(2011). Age correction in dementia – matching to a healthy brain. PLoS One, 6(7), e22193.
(2012). Brain maturation: Predicting individual BrainAGE in children and adolescents using structural MRI. NeuroImage, 63, 1305–1312.
(2010). Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: Exploring the influence of various parameters. Neuro-Image, 50, 883–892.
. (2002). Quality of life measurement: bibliographic study of patient assessed health outcome measures. British Medical Journal, 324, 1417.
(2009). Partial volume segmentation with Adaptive Maximum a Posteriori (MAP) approach. NeuroImage, 47(S1), S121.
(2010). Mapping gray matter development: Implications for typical development and vulnerability to psychopathology. Brain and Cognition, 72(1), 6–15.
(2001). A voxel-based morphometric study of aging in 465 normal adult human brains. Neuroimage, 14(1 Pt 1), 21–36.
(2008). Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology, 70(19 Pt 2), 1740–1752.
(2011). Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology, 77, 1524–1531.
(2008). Automatic classification of MR scans in Alzheimer’s disease. Brain, 131(Pt 3), 681–689.
(2011). Longitudinal development of human brain wiring continues from childhood into adulthood. Journal of Neuroscience, 31, 10937–10947.
(2006). Brain development in children and adolescents: Insights from anatomical magnetic resonance imaging. Neuroscience and Biobehavioral Reviews, 30, 718–729.
(2009). Alzheimer’s disease neuroimaging initiative: A one-year follow-up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage, 45, 645–655.
(2007). Open Access Series of Imaging Studies (OASIS): Cross-sectional MRI data in young, middle-aged, nondemented, and demented older adults. Journal of Cognitive Neuroscience, 19, 1498–1507.
(2012). The Functional Quality of Life (fQOL)-model. A new basis for quality of life-enhancing interventions in old age. GeroPsych, 25, 33–40.
(2012). Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment. Neurobiology of Aging, 33, 242–253.
(2008). A large scale (N = 400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophrenia Research, 101(1–3), 95–105.
(1996). The Alzheimer’s Disease Assessment Scale. International Psychogeriatrics, 8, 195–203.
(1988). Alzheimer’s Disease Assessment Scale (ADAS). Psychopharmacology Bulletin, 24, 627–628.
(1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43, 2412–2414.
(1994). A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Archives of Neurology, 51, 874–887.
(1997). Statistical approach to segmentation of single-channel cerebral MR images. IEEE Transactions on Medical Imaging, 16, 176–186.
(2011). Age-related changes in gene expression are accelerated in Alzheimer’s disease. Synapse, 65, 971–974.
(2009). Physical activity, diet, and risk of Alzheimer disease. Journal of the American Medical Association, 302, 627–637.
(2002). Learning with Kernels: Support vector machines, regularization, optimization, and beyond. Cambridge, MA: MIT Press.
(2011). Lessons about neurodevelopment from anatomical magnetic resonance imaging. Journal of Developmental and Behavioral Pediatrics, 32, 158–168.
(2009). Accelerating regional atrophy rates in the progression from normal aging to Alzheimer’s disease. European Radiology, 19, 2826–2833.
(2008). Lifestyle-related factors in predementia and dementia syndromes. Expert Review of Neurotherapeutics, 8(1), 133–158.
(2011). Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiology of Aging, 32, 1932–1941.
(2010). Whole brain atrophy rate predicts progression from MCI to Alzheimer’s disease. Neurobiology of Aging, 31, 1601–1605.
(2011). Age-related gray matter volume changes in the brain during nonelderly adulthood. Neurobiology of Aging, 32, 354–368.
(2000). The relevance vector machine. In S. A. Solla T. K. Leen K.-R. MüllerEds., Advances in neural information processing systems 12 (pp. 652–658). Cambridge, MA: MIT Press.
(2001). Sparse bayesian learning and the relevance vector machine. Journal of Machine Learning Research, 1, 211–244.
(2006). Mapping brain maturation. Trends in Neurosciences, 29, 148–159.
(2004). Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage, 23, 84–97.
(2010). Progression of brain atrophy and cognitive decline in diabetes mellitus: A 3-year follow-up. Neurology, 75, 997–1002.
(2003). Normative pediatric brain data for spatial normalization and segmentation differs from standard adult data. Magnetic Resonance in Medicine, 50, 749–757.
(2011). Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Archives of Neurology, 68, 351–356.
(